Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 132Terminated 26Unknown 14Withdrawn 8Active not recruiting 3Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Neoplasm, Residual 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Intraocular Lymphoma 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

venetoclax 4Cyclophosphamide 4fludarabine 3Azacitidine 3blinatumomab 2Whole-Body Irradiation 2Cytarabine 2Blood Specimen Collection 2pegaspargase 1etoposide phosphate 1capivasertib 1Vincristine 1Tretinoin 1Tissue Banks 1Tacrolimus 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Immunotherapy, Adoptive 1IPI-549 1Etoposide 1Drug Therapy, Combination 1Doxorubicin 1Dexamethasone 1Decitabine 1Calcium Dobesilate 1Busulfan 1Arsenic Trioxide 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia × Methotrexate × Clear all
NCT07227584 2025-11-12

ALL Backbone in AYAs

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting
67 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡